MYGN and SOPH Related Headlines

Go Back

Oct 8, 2026 09:01AM Myriad Genetics and SOPHiA Genetics team up on prostate cancer test

Oct 8, 2026 09:00AM Myriad Genetics and SOPHiA GENETICS Announce New Collaboration to Advance Prostate Genomic Instability Score Technology

Oct 8, 2026 09:00AM SOPHiA GENETICS and Myriad Genetics Announce New Collaboration to Advance Prostate Genomic Instability Score Technology

Nov 3, 2025 04:05PM Myriad Genetics Reports Third Quarter 2025 Financial Results; Reiterates 2025 Financial Guidance Following Continued Solid Execution

Nov 3, 2025 04:05PM Myriad Genetics Reports Third Quarter 2025 Financial Results; Reiterates 2025 Financial Guidance Following Continued Solid Execution

MYGN and SOPH Related Press Releases

Go Back

Oct 8, 2026 09:00AM Myriad Genetics and SOPHiA GENETICS Announce New Collaboration to Advance Prostate Genomic Instability Score Technology

Oct 8, 2026 09:00AM SOPHiA GENETICS and Myriad Genetics Announce New Collaboration to Advance Prostate Genomic Instability Score Technology

Nov 3, 2025 04:05PM Myriad Genetics Reports Third Quarter 2025 Financial Results; Reiterates 2025 Financial Guidance Following Continued Solid Execution

Nov 3, 2025 04:05PM Myriad Genetics Reports Third Quarter 2025 Financial Results; Reiterates 2025 Financial Guidance Following Continued Solid Execution

MYGN and SOPH Related SEC Filings

Go Back